4.5 Letter

Mutations of the gene FNIP1 associated with a syndromic autosomal recessive immunodeficiency with cardiomyopathy and pre-excitation syndrome

期刊

EUROPEAN JOURNAL OF IMMUNOLOGY
卷 50, 期 7, 页码 1078-1080

出版社

WILEY
DOI: 10.1002/eji.201948504

关键词

B cell development; cardiomyopathy; immunodeficiency; metabolism; myopathy

资金

  1. Forderverein zugunsten krebskranker Kinder Krefeld e.V.
  2. Bundesministerium fur Bildung und Forschung (PID-NET) [BMBF 01GM1517B]
  3. Centre for Personalised Immunology - National Health and Medical Research Council of Australia, NHMRC
  4. The Australian National University, Canberra, Australia
  5. European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [714226]
  6. St. Baldrick's Robert Arceci Innovations Award
  7. Deutsche Forschungsgemeinschaft

向作者/读者索取更多资源

AMPK (adenosine monophosphate-activated protein kinase) is phosphorylated (AMPK-P) in response to low energy through allosteric activation by Adenosine mono- or diphosphate (AMP/ADP). Folliculin (FLCN) and the FLCN-interacting proteins 1 and 2 (FNIP1, 2) modulate AMPK. FNIP1 deficiency patients have a AMPK-P gain of function phenotype with hypertrophic cardiomyopathy, Wolff-Parkinson-White pre-excitation syndrome, myopathy of skeletal muscles and combined immunodeficiency. (+)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据